Patients with known or suspected lower extremity peripheral artery disease (PAD) are typically evaluated in the outpatient setting by measuring the ankle-brachial index (ABI), the ratio of the lower of the ankle systolic blood pressures (BP) at each ankle to the higher arm systolic BP (1) . An ABI between 1.00 and 1.30 is considered normal, and an ABI Յ0.90 indicates the presence of PAD (2) . An ABI Ն1.40 is abnormal and a consequence of medial arterial calcification (3) in the lower extremities leading to poor compressibility or "stiffness" of the arteries. As a result, higher cuff pressure is needed to cause compression or occlusion of the arteries, resulting either in an inability to obtain an ABI (ankle BP Ͼ255 mm Hg) or a falsely elevated ABI (Ն1.40) (4) . The presence of poorly compressible arteries (PCA) in the lower extremities has been found to be highly specific for calcification of the medial layer in these arteries (4 -6) . The phenomenon has also been referred to in the literature as "calcified," "stiff," "non compressible," or "poorly compressible" vessels/arteries. In this report, we use the term "poorly compressible arteries."
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According to data from the National Health and Nutritional Examination Survey, 1.6 million adults age Ն40 years in the United States have an ABI Ͼ1.40 (7) . These individuals have a higher prevalence of diabetes, chronic kidney disease, and cardiovascular disease, and lower quality of life than those with normal ABI (8 -10) . Three previous studies (11 -13) of random samples of community-dwelling volunteers have shown that participants with a high ABI had survival rates similar to those with PAD (ABI Յ0.90).
Other than small studies (n ϭ 8 and 403, respectively) (14, 15) , limited data are available regarding survival of patients identified in the clinical setting as having PCA.
The goal of the present study was to compare patients with PCA identified in the noninvasive vascular laboratory to patients with a normal ABI, as well as to patients with PAD, in terms of prevalence of cardiovascular risk factors, comorbid conditions, and survival. We estimated survival free of death and identified predictors of survival in patients undergoing noninvasive lower extremity arterial evaluation in the outpatient setting. Knowledge of life expectancy may be useful in the care of patients with PCA by informing clinical decision-making.
Methods
Study design and population. This study used a historical cohort design. The sample consisted of consecutive adult patients who underwent outpatient lower extremity arterial evaluation for suspected or known PAD in the noninvasive vascular laboratory of the Mayo Clinic, Rochester, Minnesota, between January 1, 1998, and December 31, 2007. Since January of 1998, the results of all noninvasive lower extremity arterial evaluations have been entered into a database that becomes part of the Mayo electronic medical record (EMR). We excluded patients who: 1) refused research authorization; 2) had missing results of arterial evaluation; 3) resided outside a 500-mile radius of Rochester, Minnesota; 4) were hospitalized at the time of arterial evaluation; and 5) were aged Յ18 years at the time of arterial evaluation (Fig. 1) . Additionally, to ease interpretation of analyses, we excluded patients with borderline high ABI (1.31 to 1.39) and borderline low ABI (0.91 to 0.99) (Fig. 1) . Noninvasive lower extremity arterial evaluation. Lower extremity arterial evaluation was performed using standardized protocols in the noninvasive vascular laboratory, which is certified by the Intersocietal Commission for the Accreditation of Vascular Laboratories. Systolic BP was measured in each arm and in the dorsalis pedis and posterior tibial arteries bilaterally using a hand-held 8.3-MHz Doppler probe. The higher of the 2 arm pressures and the lower of the 2 ankle pressures were used to calculate the ABI in each leg. The ABI based on the lower ankle pressure identifies a greater number of patients at risk for adverse cardiovascular events than an ABI based on the higher ankle pressure (16) . However, since the latter has been used for calculating the ABI in several prior studies, we also performed analyses based on the higher ankle pressure (results provided in the Online Appendix) to facilitate comparison to these studies. A standard treadmill test with a speed of 1 to 2 mph and a fixed grade of 10°with continuous electrocardiographic monitoring is performed (except in patients with severe PAD, i.e., ABI Ͻ0.5, and in patients with PCA) to obtain post-exercise ABI. Doppler waveforms were recorded from each major lower extremity artery. The data were interpreted and reported by a vascular medicine specialist. Definition of normal ABI, PAD, and PCA. We defined normal ABI as 1.0 to 1.3, borderline low ABI as 0.91 to 0.99, and borderline high ABI as 1.31 to 1.39. We defined PAD as an ABI Յ0.9 at rest or 1 min after exercise. Since patients with PAD can have a normal ABI after revascularization, we used International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) procedure codes for surgical or percutaneous revascularization supplemented by manual review of medical records, to identify such individuals. Patients were classified as having PCA if any ABI was Ն1.40 or the ankle systolic BP was Ͼ255 mm Hg (upper limit of commonly used BP apparatuses) or the term "noncompressible vessels" was mentioned in the lower extremity arterial evaluation. In patients with PCA, we additionally ascertained whether abnormal Doppler waveforms (absent, monophasic, or reduced biphasic) in a lower extremity artery had been noted during the laboratory evaluation. Cardiovascular risk factors and comorbid conditions. Demographic characteristics including area of residence and ethnicity, height, and weight were obtained from the Mayo EMR, which contains both structured and free-text elements. Cardiovascular risk factors were ascertained from the EMR using previously validated algorithms that have good sensitivity and specificity compared with manual chart abstraction (17) . Smoking status and medication use were ascertained using natural language processing as previously described (18, 19) . Natural language processing was used to discover drug "named-entity" mentions from clinical notes since medications are often recorded in clinical notes as free text. Laboratory data were obtained from the EMR using a window of 1 year centered around the time of arterial evaluation. Hypertension was considered present if there were 2 BP readings of Ն140/90 mm Hg within 3 months of the date of arterial evaluation, or a prior diagnosis of hypertension and current treatment with antihypertensive medication. Diabetes was ascertained on the basis of fasting plasma glucose Ն126 mg/dl, or random glucose Ͼ200 mg/dl, or hemoglobin A 1c of Ͼ6.5%, or a prior diagnosis and use of oral hypoglycemic agent(s) or insulin. Comorbid conditions such as coronary heart disease (CHD), cerebrovascular disease, heart failure, chronic kidney disease, malignancy, and chronic obstructive pulmonary disease were ascertained on the basis of the presence of relevant ICD-9-CM diagnosis and procedure codes for up to 6 months following the date of arterial evaluation (17) . The presence of critical limb ischemia in the study groups was ascertained based on ICD-9-CM diagnosis codes 440.22 to 440.24. Ascertainment of survival. The follow-up period for each patient was the time between the first arterial evaluation and the earliest of date of death or final censoring date (September 30, 2009). Death was ascertained initially from the Mayo EMR. For persons who were not noted as being deceased, we used the Accurint database (Seisint, West Palm Beach, Florida) to ascertain vital status. According to the EMR and the Accurint database, the number of decedents was 4,365 (26% of the study cohort). Statistical analysis. Demographic and physical characteristics, laboratory values, cardiovascular risk factors, and comorbid conditions were summarized as mean Ϯ standard deviation for continuous variables and as frequencies and percentages for categorical variables. To assess the effect of age and sex on the prevalence of PCA, we performed logistic regression analyses. Differences in demographic and clinical characteristics between the 3 study groups were tested with an analysis of covariance for continuous variables and by logistic regression for binary categorical variables, adjusting for age and sex. A p value of Ͻ0.05 was considered statistically significant. We computed the Kaplan-Meier survival curves in the 3 groups of patients and compared survival using the 1-sample log-rank test.
We constructed a series of multivariable Cox proportional hazards models to estimate hazard ratios for death in the PCA patients compared with the normal ABI group and PAD groups, starting with an unadjusted model and then adjusting for age and sex, and then additionally for body mass index (BMI), CHD, cerebrovascular disease, heart failure, diabetes, hypertension, chronic kidney disease, malignancy, chronic obstructive pulmonary disease, smoking, and medication (statin and aspirin) use, and finally, for the presence of critical limb ischemia. We assessed whether interactions existed between PCA and age and sex in predicting hazard of dying compared with patients with a normal ABI and PAD. The multivariable Cox proportional hazards models were repeated in strata defined by any significant interactions. We furthermore identified predictors of survival and estimated the associated hazard ratios, using these same Cox proportional hazards models. To address the possibility of a referral bias, we included Olmsted County residency as a predictor variable, and also repeated the multivariable Cox proportional hazards models stratified by Olmsted County residency. Finally, we assessed whether the presence of abnormal arterial Doppler signals in PCA patients resulted in an additional increase in risk of mortality and whether defining PAD as ABI Ͻ1.0 and PCA as ABI Ն1.3 altered inferences. Statistical analysis was performed using SAS version 9.1 (SAS Institute, Cary, North Carolina).
Results
A total of 22,859 patients underwent noninvasive lower extremity arterial evaluation between January 1, 1998, and December 31, 2007. After applying the initial exclusion criteria, 17,485 remained (Fig. 1) . Additionally, we removed patients with borderline low ABI (0.91 to 0.99) and borderline high ABI (1.31 to 1.39) to arrive at the final study sample of 16,493 patients (59% men, 98% nonHispanic white, mean age 67.8 Ϯ 13.0 years). Of these, 4,754 (29%) patients had a normal ABI (1.00 to 1.30) and 8,958 patients (54%) had PAD. The latter included 158 patients with a normal ABI who had previously undergone lower extremity revascularization for symptomatic PAD. A significant proportion (17%, n ϭ 2,781) of patients had PCA ( Table 1 ). The prevalence of critical limb ischemia was significantly higher in patients with PCA than in patients with PAD (Table 1) . Abnormal Doppler arterial waveforms were present in 1,976 (71%) of PCA patients. The proportion of patients with normal ABI, PAD, and PCA among men and women of various age ranges is shown in Figure 2 . The prevalence of PCA was higher in men (p Ͻ 0.001) than in women and increased with age (p Ͻ 0.001) in both men and women. Patients with PAD or PCA were older than the reference group. Other patient characteristics were compared after adjustment for age and sex (Table 1) .
Pulse pressure was higher in the PCA and PAD groups than the normal ABI group. Fasting serum glucose and serum creatinine were highest in the PCA group. Among cardiovascular risk factors, diabetes and hypertension were more prevalent in patients with PCA, whereas history of smoking was more common in patients with PAD (Table 1 ). In the PCA group, a higher proportion of patients had coexisting CHD, heart failure, and chronic kidney disease than in the normal ABI and PAD groups (Table 1) . On the other hand, the proportion of patients with cerebrovascular disease and chronic obstructive pulmonary disease was highest in the PAD group (Table 1) . The proportion of patients on a statin medication or aspirin was higher in the PCA and PAD groups than the normal ABI group, but was not significantly different between PCA and PAD groups ( Table 1) .
The mean follow-up for the entire group was 5.8 Ϯ 3.1 years (median: 5.6 years, interquartile range: 3.2 to 8.3 years). As of September 30, 2009, 4,365 (26%) patients had died; a greater proportion of patients with PCA died (n ϭ 1,123, 40%), followed by PAD patients (n ϭ 2,649, 30%), and patients with a normal ABI (n ϭ 593, 12%). The estimated percent survival at 5 years was lowest in the PCA group (74%), followed by the PAD (79%) and normal ABI (86%) groups. Kaplan-Meier survival curves over 12 years of follow-up are shown in Figure 3 . The curves start to separate early, and survival in PCA group was worse than in the PAD and normal ABI groups.
We estimated the relative hazard of death in patients with PAD and PCA using multivariable Cox proportional hazards regression. In the unadjusted model, compared with patients with normal ABI, the hazard of death was 2.5-fold higher in patients with PAD and 4.0-fold higher in patients with PCA (Table 2 ). In the model that adjusted for age, sex, and comorbid conditions, the hazard of death was 1.6-fold higher in patients with PAD, and 2.0-fold higher in patients with PCA than those with normal ABI (Table 2) .
When we compared patients with PCA to patients with PAD, the former had 60% higher hazard of death (hazard ratio [HR]: 1.6, 95% confidence interval [CI]: 1.5 to 1.7) in the unadjusted model and 30% higher hazard of death (HR: 1.3, 95% CI: 1.2 to 1.4) after adjustment for age sex and comorbid conditions ( Table 2 ). The presence of PCA was associated with increased hazard of death even after additional adjustment for critical limb ischemia (Table 2) . We found significant interactions between presence of PCA and sex in influencing the hazard of death compared with patients with a normal ABI (p Ͻ 0.001) and PAD (p Ͻ 0.007). We therefore performed analyses stratified by sex. Compared with patients with normal ABI, the hazard of death associated with PCA was greater in women (2.6) than in men (1.7) ( Table 2 ). Compared with patients with PAD, the hazard of death associated with PCA was also greater in women (1.5) than in men (1.3) ( Table 2 ). Olmsted County residency was associated with a greater hazard of death, consistent with a modest referral bias. However, in analyses stratified by Olmsted County residency, the hazard ratios associated with PCA and other predictor variables were similar in magnitude (Table 3) .
In the fully adjusted model, factors in addition to PCA that were associated with an increased hazard of dying were hypertension, diabetes, history of smoking, CHD, cerebrovascular disease, heart failure, chronic obstructive pulmonary disease, chronic kidney disease, and malignancy (Table 3) . A higher BMI, and statin and aspirin use were associated with a reduced hazard of death (Table 3 ). In patients with PCA, the presence of abnormal Doppler arterial waveforms was associated with an incremental hazard of death independent of age, sex, cardiovascular risk factors, comorbid conditions, and medication use (HR: 1.55, 95% CI: 1.31 to 1.83; pϽ0.0001). When we used criteria for PAD as ABI
Figure 2 Age and Sex Distribution in the 3 Study Groups
The proportion of patients with normal ABI, PAD, and PCA among men and women of various age ranges. The prevalence of PCA was higher in men (p Ͻ 0.001) than in women and increased with age (p Ͻ 0.001) in both men and women. Abbreviations as in Figure 1 . Values are mean Ϯ SD and n (%). Differences in age and sex between study groups were significant at p Ͻ 0.001. Age-and sex-adjusted differences in the remaining patient characteristics were also significant at p Ͻ 0.001, except for Olmsted County residency (p ϭ 0.007). ABI ϭ ankle brachial index; BMI ϭ body mass index; BP ϭ blood pressure; COPD ϭ chronic obstructive pulmonary disease; PAD ϭ peripheral arterial disease; PCA ϭ poorly compressible arteries. When analyses were repeated using the higher of the 2 ankle pressures to calculate the ABI, the inferences were unchanged. The results of these analyses are summarized in the Online Appendix.
Patient Characteristics

Discussion
In this historical cohort study of patients referred for a noninvasive arterial evaluation, patients who met criteria for PCA had significantly lower survival than patients with PAD and those with normal ABI. Among patients with PCA, 40% died by the end of the study period, a significantly higher proportion than in patients with PAD (30%) and normal ABI (12%). Having PCA was associated with 4.0-and 1.6-fold unadjusted higher hazard of death than the normal ABI and PAD groups, respectively. The higher risk of death appeared to be due in part to greater age and higher prevalence of comorbid conditions and cardiovascular risk factors. After adjustment for age, sex, cardiovascular risk factors, comorbid conditions, and medication use, patients with PCA were at a 2.0-and 1.3-fold higher risk of death than the normal ABI and PAD groups, respectively. The hazard of death due to PCA was higher in women than in men.
Three previous cohort studies showed a U-shaped association between ABI and survival (11) (12) (13) . These studies used different criteria to label patients as having normal ABI, PAD, and PCA. The Strong Heart Study (11) included 4,393 American Indians, grouped into low (Յ0.90), normal (0.90 to 1.40), and high ABI (Ͼ1.40) categories. Participants with borderline-low and borderlinehigh ABI were included in the "reference category." During a mean follow-up of 8.3 Ϯ 2 years, 1,022 participants died. The adjusted HR of death was 1.7 in the PAD group and 1.8 in the high ABI group (11) . In the Cardiovascular Health Study (12), 5,748 Medicare-eligible adults were followed for a mean of 11.1 years. The adjusted HR of death increased at ABI values above and below the normal range (1.00 to 1.30). Compared with the normal ABI group, the HR of death in the high ABI (Ͼ1.40) group was 1.60. However, this study excluded patients in whom ABI could not be calculated, and therefore may have included only a "milder" form of PCA (12) . In the MESA (Multiethnic Study of Atherosclerosis) (13), 6,647 non-Hispanic white, African-American, Hispanic, and Chinese men and women age 45 to 84 years without history of myocardial infarction or stroke, underwent measurement of ABI. After adjustment for both traditional and newer cardiovascular risk factors, hazard ratios for a low (Ͻ1.0) and high (Ͼ1.40) ABI were 1.77 and 1.85, respectively.
In contrast to these 3 studies (11-13) in which survival of patients with high ABI was similar to those with PAD, we found that the adjusted HR for death was higher in patients with PCA than those with PAD. A cross-sectional study of 7,155 patients age Ͼ50 years from 350 primary care sites found those with ABI Ն1.40 at higher odds for foot ulcer, neuropathy, heart failure, and stroke after adjustment for traditional risk factors, compared with those with normal ABI (20) . Our results confirm that both PAD and PCA are associated with reduced survival compared with patients with a normal ABI, and in addition, demonstrate that having PCA carries 30% (adjusted) higher risk of death than having PAD. This is an important finding, given that the presence of PAD in itself is associated with a relatively poor prognosis (21-24). Olmsted County residency was associ- Figure 3 Kaplan-Meier Survival Curves in the 3 Study Groups
The number of patients in each study group at 1, 5, and 10 years of follow-up are listed. Abbreviations as in Figure 1 .
ated with a modestly greater hazard of death in our study cohort, suggesting a "healthy person" referral bias. In other words, patients from outside of the Olmsted County were "healthier" and able to travel to Rochester, Minnesota, for further evaluation of leg symptoms. However, in analyses stratified by Olmsted County residency, the relative hazards associated with the predictor variables, including the presence of PCA, were similar. In a study (15) of 403 hospitalized diabetic patients, the presence of PCA and abnormal Doppler, but not PCA alone, was associated with a higher risk of cardiovascular events. By contrast, the presence of PCA with normal Doppler waveforms in our study was associated with increased risk of mortality compared with those with normal ABI (fully adjusted HR: 1.4, 95% CI: 1.2 to 1.6) but not when compared with patients with PAD (fully adjusted HR: 0.9, 95% CI: 0.8 to 1.1). The presence of abnormal Doppler in patients with PCA was associated with a significant increment in the risk of death, suggesting that concomitant atherosclerosis adds to the risk due to medial arterial calcification. Whether the presence of PCA is merely a marker of increased risk or directly contributes to increased mortality is unknown.
One potential mechanism of increased risk is greater arterial stiffness in patients with PCA. We found systolic BP and pulse pressure to be higher in the PCA and PAD groups than in normal ABI group. In MESA (6), participants with PCA had greater left ventricular mass than patients with the normal or low ABI. The authors postulated that medial artery calcification leads to increased arterial stiffness and increased left ventricular afterload, thereby increasing left ventricular mass (6) . Consistent with this hypothesis, we previously demonstrated that serum N-terminal pro-B-type natriuretic peptide levels are significantly higher in patients with PCA than in patients with normal ABI and those with PAD (25) . An additional mechanism could be the high prevalence of critical limb ischemia in patients with PCA. However, even after additional adjustment for the presence of critical limb ischemia, patients with PCA had a higher hazard of dying than patients with or without PAD.
Our study has several important clinical implications. First, a substantial proportion of patients (17% in the present study) referred for noninvasive lower extremity arterial evaluation had PCA. The prevalence of PCA is likely to increase as a result of aging and increased prevalence of diabetes, highlighting the need for increased awareness of this entity (26) . Second, the presence of PCA in older adults indicates increased risk of mortality and motivates further investigation to identify factors whose modification would improve survival. Finally, among the 3 groups in our study, patients with PCA had the highest prevalence of diabetes, heart failure, and chronic kidney disease. Together with prior studies that have reported an increased risk of amputation and poor quality of life in patients (20, (27) (28) (29) , these data indicate a high level of comorbidity and healthcare burden associated with PCA. Identifying risk factors for medial arterial calcification and treating such factors is important, given that treatment options for vascular calcification are limited (30) . Strengths and limitations. A strength of the present study is the large sample of patients who underwent standardized evaluation in an accredited noninvasive vascular laboratory. To the best of our knowledge, the 2,781 patients with PCA comprise the largest reported cohort of such patients to date. Although we attempted to limit referral bias by excluding patients who lived outside of a 500-mile radius of our medical center, and also performed sensitivity analyses using Olmsted County residency as a stratification variable, our survival estimates need to be validated in additional studies. The study cohort was almost entirely non-Hispanic white, and whether our findings can be generalized to other racial and ethnic groups needs further study. We did not have imaging studies available to confirm medial arterial calcification in patients with PCA, nor did we have information on all adverse cardiovascular events or the cause of death.
Conclusions and Future Directions
A significant proportion of patients referred for noninvasive lower extremity arterial evaluation had PCA, and survival in such patients was lower than in those with a normal ABI, and even lower than in patients with PAD. After adjusting for age, sex, cardiovascular risk factors, comorbid conditions, and medications, the hazard of dying in the PCA group was 2.0-fold higher than in those with normal ABI and 1.3-fold lower than those with ABI Յ0.90. The hazard of dying associated with PCA was higher in women than in men. There was an increased prevalence of comorbid conditions in patients with PCA, especially diabetes, heart failure, and chronic kidney disease. However, other as yet unidentified factors may contribute to reduced survival in patients with PCA. Further investigation is needed to identify mechanisms that lead to development of PCA (30 -36) , identify mediators of poor survival, and explore treatment options to improve survival in these high-risk patients.
